INS and Hyperglycemia: Moreover, their preclinical study shows that continuous systemic leptin administration ameliorates hyperglycemia and that it can reduce dosage of insulin for anti-diabetic treatment, suggesting that leptin may be applicable in the clinical setting as an adjuvant to insulin therapy (Wang et al., 2010).